webinar register page

Webinar banner
NeoGenomics Gastrointestinal Tract Cancer Tumor Board
NeoGenomics is proud to offer our Molecular Tumor Boards covering relevant topics in cancer care.

Each session, multidisciplinary teams will submit and discuss 2 - 4 patients with expert oncologists. For more information on this and our other tumor boards, please visit https://neogenomics.com/client-services/education/tumor-boards (copy and paste into browser).

Upcoming dates:

December 8

We look forward to having you join us. Please contact the Scientific Collaboration & Engagement team at tumorboards@neogenomics.com to inquire about submitting cases for review, or for any questions.
Dec 8, 2021 09:00 AM
Time shows in
Webinar logo
* Required information


Shumei Kato, MD
Assistant Professor, Department of Medicine @UC San Diego Health
Shumei Kato, MD, is a board-certified medical oncologist who specializes in treating rare cancers and gastrointestinal tumors. He uses numerous forms of therapy such as chemotherapy, biological therapy, immunotherapy and targeted therapy to offer the best possible treatment options for his patients. Dr. Kato has a special interest in targeted molecular therapy and his approach to care emphasizes personalized medicine and experimental therapeutics. As an assistant professor in the Department of Medicine, Dr. Kato instructs medical students, residents and fellows. His research interests include clinical trials and the design of new, more effective drugs for individualized therapy. Dr. Kato has coauthored peer-reviewed articles, which have been published in Nature Cell Biology and the Journal of the National Cancer Institute, among others.